Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.

Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D.

Brain. 2019 Jul 20. pii: awz193. doi: 10.1093/brain/awz193. [Epub ahead of print]

PMID:
31327002
2.

Brain responses to virtual reality visual motion stimulation are affected by neurotic personality traits in patients with persistent postural-perceptual dizziness.

Passamonti L, Riccelli R, Lacquaniti F, Staab JP, Indovina I.

J Vestib Res. 2018;28(5-6):369-378. doi: 10.3233/VES-190653.

PMID:
30856138
3.

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2019 Jan 2;6(2):373-378. doi: 10.1002/acn3.683. eCollection 2019 Feb.

4.

A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.

Spasov S, Passamonti L, Duggento A, Liò P, Toschi N; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2019 Apr 1;189:276-287. doi: 10.1016/j.neuroimage.2019.01.031. Epub 2019 Jan 14.

PMID:
30654174
5.

A realistic neuronal network and neurovascular coupling model for the study of multivariate directed connectivity in fMRI data.

Duggento A, Passamonti L, Guerrisi M, Toschi N.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:5537-5540. doi: 10.1109/EMBC.2018.8513589.

PMID:
30441591
6.

A Multi-modal Convolutional Neural Network Framework for the Prediction of Alzheimer's Disease.

Spasov SE, Passamonti L, Duggento A, Lio P, Toschi N.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1271-1274. doi: 10.1109/EMBC.2018.8512468.

PMID:
30440622
7.

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2018 Sep 17;10:678-687. doi: 10.1016/j.dadm.2018.08.005. eCollection 2018.

8.

Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vázquez Rodríguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Brain. 2018 Dec 1;141(12):3415-3427. doi: 10.1093/brain/awy265.

9.

[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion.

Bevan-Jones RW, Cope TE, Jones SP, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FA, Patterson K, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2018 Sep 14;5(10):1292-1296. doi: 10.1002/acn3.631. eCollection 2018 Oct.

10.

Intra-cortical myelin mediates personality differences.

Toschi N, Passamonti L.

J Pers. 2019 Aug;87(4):889-902. doi: 10.1111/jopy.12442. Epub 2018 Nov 13.

PMID:
30317636
11.

Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.

Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, Passamonti L, Bevan-Jones WR, Regenthal R, Chamberlain SR, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2018 Dec;43(13):2645-2651. doi: 10.1038/s41386-018-0229-z. Epub 2018 Sep 26.

12.

Neuroinflammation in Neurodegenerative Diseases: Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI.

Aiello M, Cavaliere C, Fiorenza D, Duggento A, Passamonti L, Toschi N.

Neuroscience. 2019 Apr 1;403:125-135. doi: 10.1016/j.neuroscience.2018.07.033. Epub 2018 Jul 30. Review.

PMID:
30071279
13.

Reduced cortical folding in multi-modal vestibular regions in persistent postural perceptual dizziness.

Nigro S, Indovina I, Riccelli R, Chiarella G, Petrolo C, Lacquaniti F, Staab JP, Passamonti L.

Brain Imaging Behav. 2019 Jun;13(3):798-809. doi: 10.1007/s11682-018-9900-6.

14.

[11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.

Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB.

Neurology. 2018 May 29;90(22):e1989-e1996. doi: 10.1212/WNL.0000000000005610. Epub 2018 Apr 27.

15.

Psychopathic traits influence amygdala-anterior cingulate cortex connectivity during facial emotion processing.

Ewbank MP, Passamonti L, Hagan CC, Goodyer IM, Calder AJ, Fairchild G.

Soc Cogn Affect Neurosci. 2018 May 1;13(5):525-534. doi: 10.1093/scan/nsy019.

16.

Multivariate Granger causality unveils directed parietal to prefrontal cortex connectivity during task-free MRI.

Duggento A, Passamonti L, Valenza G, Barbieri R, Guerrisi M, Toschi N.

Sci Rep. 2018 Apr 3;8(1):5571. doi: 10.1038/s41598-018-23996-x.

17.

Persistent postural-perceptual dizziness: a useful new syndrome.

Seemungal BM, Passamonti L.

Pract Neurol. 2018 Feb;18(1):3-4. doi: 10.1136/practneurol-2017-001817. Epub 2018 Jan 4. No abstract available.

18.

Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.

Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, Passamonti L, Vazquez Rodriguez P, Bevan-Jones WR, O'Brien JT, Rowe JB.

Brain. 2018 Feb 1;141(2):550-567. doi: 10.1093/brain/awx347.

19.

Altered Insular and Occipital Responses to Simulated Vertical Self-Motion in Patients with Persistent Postural-Perceptual Dizziness.

Riccelli R, Passamonti L, Toschi N, Nigro S, Chiarella G, Petrolo C, Lacquaniti F, Staab JP, Indovina I.

Front Neurol. 2017 Oct 17;8:529. doi: 10.3389/fneur.2017.00529. eCollection 2017.

20.

[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer TD, Arnold R, Allinson KSJ, Coles JP, Aigbirhio FI, Patterson K, O'Brien JT, Rowe JB.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1032-1037. doi: 10.1136/jnnp-2017-316402. Epub 2017 Sep 14.

Supplemental Content

Loading ...
Support Center